Form 4: Tenet Healthcare Director Sells $521K in Stock

Tenet Healthcare Corp. Director Richard W. Fisher sold 2,500 shares of common stock for approximately $521,075 on October 29, 2025.

Summary

• Richard W. Fisher, a Director of Tenet Healthcare Corp. (THC), reported a sale of common stock.
• The transaction occurred on October 29, 2025.
• Fisher disposed of 2,500 shares of common stock at a price of $208.43 per share.
• The total value of the shares sold was approximately $521,075.
• Following this transaction, Fisher beneficially owns 8,792 shares of Tenet Healthcare Corp. common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A director's sale of shares, particularly when executed under a pre-arranged 10b5-1 plan, is generally considered a routine disclosure and does not typically indicate a significant shift in company fundamentals or insider confidence.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, potentially suggesting a lack of confidence, though the pre-planned nature mitigates this.

Related Party Transactions

• The reported transaction is a sale of common stock by a director, which is a related party transaction.

Stakeholder Impact

• Shareholders may note the director's sale, but the impact is likely minimal given the pre-planned nature of the transaction under a 10b5-1 plan and the remaining beneficial ownership.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned sale of a relatively small portion of a director's holdings under a 10b5-1 plan. Such a transaction typically does not signal a significant change in the company's fundamentals or outlook, nor does it suggest a strong buy or sell signal. Investors should continue to hold based on broader company performance and market conditions rather than this specific insider transaction.

Keywords

Tenet Healthcare, THC, Richard W. Fisher, Director, Stock Sale, Insider Trading, Form 4, SEC Filing, Common Stock, 10b5-1 Plan